← Back to Search

Other

Cranberry Juice Product for Attention Deficit Disorder

N/A
Waitlist Available
Led By Alice Eggleston, PA-C, MPH
Research Sponsored by Ocean Spray Cranberries, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 days
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if different cranberry-based drinks can improve attention, alertness, performance, and mood in healthy adults aged 18-45. The drinks include cranberry juice alone or mixed with lemon balm, tart cherry, or L-theanine. These ingredients are thought to boost brain function and reduce stress. Cranberries are rich in polyphenols, which have been studied for their potential health benefits, including improving vascular function and reducing symptoms of colds and influenza.

Eligible Conditions
  • Attention Deficit Disorder
  • Depression

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
To evaluate in healthy adults the effect of 7-day consumption of cranberry beverages compared to placebo on attention.
Secondary study objectives
To evaluate in healthy adults the effect of 7-day consumption of cranberry beverages compared to placebo on measures of alertness.
To evaluate in healthy adults the effect of 7-day consumption of cranberry beverages compared to placebo on measures of cognition (accuracy of performance).
To evaluate in healthy adults the effect of 7-day consumption of cranberry beverages compared to placebo on measures of cognition (speed of performance).
+3 more
Other study objectives
To evaluate in healthy adults the safety and tolerability of 7-day consumption of cranberry beverages compared to placebo (Blood Pressure).
To evaluate in healthy adults the safety and tolerability of 7-day consumption of cranberry beverages compared to placebo (Body Temperature).
To evaluate in healthy adults the safety and tolerability of 7-day consumption of cranberry beverages compared to placebo (Heart Rate).
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

6Treatment groups
Experimental Treatment
Group I: Third Product Order: order not stated to protect study blindingExperimental Treatment1 Intervention
Participants will receive each of the 6 study products sequentially in a cross-over design, consuming one study product for 7 days, followed by a 7 day wash-out period before beginning the next product in the sequence
Group II: Sixth Product Order: order not stated to protect study blindingExperimental Treatment1 Intervention
Participants will receive each of the 6 study products sequentially in a cross-over design, consuming one study product for 7 days, followed by a 7 day wash-out period before beginning the next product in the sequence
Group III: Second Product Order: order not stated to protect study blindingExperimental Treatment1 Intervention
Participants will receive each of the 6 study products sequentially in a cross-over design, consuming one study product for 7 days, followed by a 7 day wash-out period before beginning the next product in the sequence
Group IV: Fourth Product Order: order not stated to protect study blindingExperimental Treatment1 Intervention
Participants will receive each of the 6 study products sequentially in a cross-over design, consuming one study product for 7 days, followed by a 7 day wash-out period before beginning the next product in the sequence
Group V: First Product Order: order not stated to protect study blindingExperimental Treatment1 Intervention
Participants will receive each of the 6 study products sequentially in a cross-over design, consuming one study product for 7 days, followed by a 7 day wash-out period before beginning the next product in the sequence.
Group VI: Fifth Product Order: order not stated to protect study blindingExperimental Treatment1 Intervention
Participants will receive each of the 6 study products sequentially in a cross-over design, consuming one study product for 7 days, followed by a 7 day wash-out period before beginning the next product in the sequence
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cranberry Juice Product
2021
N/A
~30

Find a Location

Who is running the clinical trial?

Atlantia Food Clinical TrialsIndustry Sponsor
42 Previous Clinical Trials
4,256 Total Patients Enrolled
Ocean Spray Cranberries, Inc.Lead Sponsor
6 Previous Clinical Trials
498 Total Patients Enrolled
Alice Eggleston, PA-C, MPHPrincipal InvestigatorAtlantia Clinical Trials Ltd.
1 Previous Clinical Trials
60 Total Patients Enrolled
~6 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top